Randomised, Double Blind, Placebo Controlled Trial of Angiotensin Converting Enzyme Inhibitors and Statins in the Prevention of Long Term Complications in Young People With Type 1 Diabetes
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Atorvastatin (Primary) ; Quinapril (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- Acronyms AdDIT
- 07 Jun 2017 Biomarkers information updated
- 26 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Apr 2017.
- 26 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Apr 2017.